mesalazine
UkraineDrugs containing this active substance
-
The drug is indicated for the treatment of mild to moderate ulcerative colitis, as well as for maintenance therapy during remission.
Form: tablets, modified release
Active substance Dosage mesalazine 1600 mg ATC: A07EC02
Manufacturer: Tilots Pharma AG (manufacturer responsible for batch release)
-
The drug is used for the treatment of ulcerative colitis (from mild to moderate severity), as well as for the maintenance of remission in this disease. It is also used in Crohn's disease.
Form: tablets, coated, enteric-coated
Active substance Dosage mesalazine 400 mg ATC: A07EC02
Manufacturer: Haupt Pharma Wülfling GmbH (manufacturing of unpackaged products, primary and secondary packaging)
-
The drug is used for the treatment of ulcerative colitis (from mild to moderate) and Crohn's disease. It is also used to maintain remission in ulcerative colitis.
Form: tablets, coated, enteric-coated
Active substance Dosage mesalazine 800 mg ATC: A07EC02
Manufacturer: Haupt Pharma Wülfling GmbH (manufacturing of unpackaged products, primary and secondary packaging)
-
The drug is used by adults for the treatment of mild to moderate proctitis and proctosigmoiditis, as well as as adjunctive therapy for severe forms of ulcerative colitis affecting the rectum or rectosigmoid region.
Form: suppositories, rectal
Active substance Dosage mesalazine 500 mg ATC: A07EC02
Manufacturer: Tilots Pharma AG (manufacturer responsible for batch release)
-
The drug is used for the treatment of ulcerative colitis (from mild to moderate) and Crohn's disease. It is also used for maintenance therapy during the remission stage.
Form: tablets, coated, enteric-coated
Active substance Dosage mesalazine 400 mg ATC: A07EC02
Manufacturer: San Pharmaceutical Industries Ltd
-
The drug is used to treat exacerbations of ulcerative colitis limited to the rectum (ulcerative proctitis).
Form: suppositories
Active substance Dosage mesalazine 1000 mg ATC: A07EC02
Manufacturer: Kusum HealthCare Pvt Ltd
-
The drug is used for the treatment of ulcerative proctitis.
Form: suppositories, rectal
Active substance Dosage mesalazine 1000 mg ATC: A07EC02
Manufacturer: Ferring International Center SA (manufacturing)
-
The drug is used for the treatment of ulcerative colitis (from mild to moderate severity) and Crohn's disease.
Form: tablets, extended-release
Active substance Dosage mesalazine 500 mg ATC: A07EC02
Manufacturer: Ferring International Center SA (manufacturing)
-
The drug is used for the treatment of ulcerative colitis and Crohn's disease.
Form: granules, prolonged action
Active substance Dosage mesalazine 1 g ATC: A07EC02
Manufacturer: Ferring International Center SA (responsible for manufacturing, primary and secondary packaging, quality control)
-
The drug is used for the treatment of ulcerative colitis and Crohn's disease.
Form: granules, prolonged action
Active substance Dosage mesalazine 2 g ATC: A07EC02
Manufacturer: Ferring International Center SA (responsible for manufacturing, primary and secondary packaging, quality control)
-
The drug is prescribed for the treatment of ulcerative proctosigmoiditis and left-sided colitis.
Form: suspension, rectal
Active substance Dosage mesalazine 1 g/100 ml ATC: A07EC02
Manufacturer: Ferring-Lekhiva a.s.
-
The drug is used for the treatment of exacerbations and the prevention of relapses of mild to moderate ulcerative colitis.
Form: granules, gastroresistant, prolonged-release
Active substance Dosage mesalazine 500 mg ATC: A07EC02
Manufacturer: Dr. Falk Pharma GmbH (manufacturer responsible for batch release of the final product)
-
The drug is used for the treatment of exacerbations and the prevention of relapses of mild to moderate ulcerative colitis.
Form: granules, gastroresistant, prolonged-release
Active substance Dosage mesalazine 1000 mg ATC: A07EC02
Manufacturer: Dr. Falk Pharma GmbH (manufacturer responsible for batch release of the final product)
-
The drug is used for the treatment of exacerbations and the prevention of relapses of mild to moderate ulcerative colitis.
Form: granules, gastroresistant prolonged-release
Active substance Dosage mesalazine 3 g ATC: A07EC02
Manufacturer: Dr. Falk Pharma GmbH (responsible for batch release of the final product)
-
The drug is used for the treatment of exacerbations and the prevention of relapses of mild to moderate ulcerative colitis.
Form: granules, gastroresistant prolonged-release
Active substance Dosage mesalazine 1.5 g ATC: A07EC02
Manufacturer: Dr. Falk Pharma GmbH (responsible for batch release of the final product)
-
The drug is used to treat exacerbations of ulcerative colitis (a chronic inflammatory disease of the large intestine).
Form: suspension, rectal
Active substance Dosage mesalazine 4 g ATC: A07EC02
Manufacturer: Dr. Falk Pharma GmbH (responsible for batch release of the final product)
-
The drug is used to treat exacerbations of ulcerative colitis limited to the rectum, as well as to maintain remission of this disease.
Form: suppositories, rectal
Active substance Dosage mesalazine 250 mg ATC: A07EC02
Manufacturer: Dr. Falk Pharma GmbH (responsible for batch release of the final product)
-
The drug is used to treat exacerbations of ulcerative colitis limited to the rectum, as well as to maintain remission of this disease.
Form: suppositories, rectal
Active substance Dosage mesalazine 500 mg ATC: A07EC02
Manufacturer: Dr. Falk Pharma GmbH (responsible for batch release of the final product)
-
The drug is used to treat exacerbations of ulcerative colitis limited to the rectum (ulcerative proctitis).
Form: suppositories, rectal
Active substance Dosage mesalazine 1000 mg ATC: A07EC02
Manufacturer: Dr. Falk Pharma GmbH (Responsible for release of final product batches)
-
The drug is used for the treatment of exacerbations and the prevention of relapses in ulcerative colitis, as well as for the treatment of exacerbations of Crohn's disease.
Form: tablets, coated, enteric-coated
Active substance Dosage mesalazine 500 mg ATC: A07EC02
Manufacturer: Dr. Falk Pharma GmbH (manufacturer responsible for batch release of the final product)